FDA Inspection 1232268 — OsteoMed, LLC

OsteoMed, LLC — FEI 2027754

The FDA completed an inspection of OsteoMed, LLC on August 16, 2024 in Addison, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Addison, TX (United States)